抗凝药物审方规则专家共识

重庆市医院协会药事管理专业委员会

doi:10.6039/j.issn.1001-0408.2023.24.02

您当前的位置：

首页 >

文章列表页 >

抗凝药物审方规则专家共识

医药热点 | 更新时间：2023-12-22

- 抗凝药物审方规则专家共识
- Expert consensus on prescription review rules of anticoagulants
- 中国药房 2023年34卷第24期页码：2951-2967
- 作者机构：
- 作者简介：
  
  赵春景：主任药师，博士。研究方向：医院药学。E-mail：zhaocj6547@sina.com
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.24.02
  中图分类号： R95;R972;R973
- 纸质出版日期：2023-12-30，
  
  收稿日期：2023-09-11，
  
  修回日期：2023-11-20，
扫描看全文
重庆市医院协会药事管理专业委员会.抗凝药物审方规则专家共识 ^Δ[J].中国药房,2023,34(24):2951-2967.

.Expert consensus on prescription review rules of anticoagulants[J].ZHONGGUO YAOFANG,2023,34(24):2951-2967.
重庆市医院协会药事管理专业委员会.抗凝药物审方规则专家共识 ^Δ[J].中国药房,2023,34(24):2951-2967. DOI： 10.6039/j.issn.1001-0408.2023.24.02.

.Expert consensus on prescription review rules of anticoagulants[J].ZHONGGUO YAOFANG,2023,34(24):2951-2967. DOI： 10.6039/j.issn.1001-0408.2023.24.02.

摘要

目的

为进一步规范抗凝药物的临床应用，提高医疗机构抗凝药物处方的审核效率提供参考。

方法

由重庆市医院协会药事管理专业委员会发起，重庆医科大学附属第二医院牵头，联合全国多个省份的相关领域专家，基于药品说明书建立12种常用抗凝药物的基础审方规则、警示级别及对应干预措施；针对基础审方规则中未涵盖的部分临床应用情况，在参考已有指南及专家共识的基础上，向来自全国8个省份22家医院的42名专家进行函询，形成共识。结果与

结论

基于药品说明书建立了普通肝素、依诺肝素钠、那屈肝素钙、达肝素钠、磺达肝癸钠、比伐芦定、阿加曲班、华法林、达比加群酯、利伐沙班、阿哌沙班、艾多沙班共12种抗凝药物的基础审方规则，以及超出基础审方规则的警示级别及对应干预措施。针对基础审方规则中未涵盖的部分临床应用情况，经过2轮专家函询，形成了17条审方推荐意见。随着临床研究的进展，本共识将会进一步更新和调整；此外，因本共识未涵盖抗凝药物在临床使用的所有情况，审方人员须针对患者具体情况进行个体化评估。

Abstract

OBJECTIVE

To further standardize the clinical application of anticoagulants and provide reference for improving the efficiency of prescription review of anticoagulants in medical institutions.

METHODS

Initiated by the Pharmaceutical Administration Committee of Chongqing Hospital Association and led by the Second Affiliated Hospital of Chongqing Medical University， in collaboration with experts in relevant fields from multiple provinces across the country， the prescription review rules， warning levels， and intervention measures for 12 kinds of common anticoagulants were established based on drug instructions. Regarding clinical drug use that was not covered by the basic review rules， based on reference to existing guidelines and expert consensus， 42 experts from 22 hospitals in 8 provinces across the country were consulted by letter to form a consensus.

RESULTS

CONCLUSIONS

The basic prescription review rules of 12 kinds of anticoagulants， including unfractionated heparin， enoxaparin sodium， nadroparin calcium， dalteparin sodium， fondaparinux sodium， bivalirudin， argatroban， warfarin， dabigatran etexilate， rivaroxaban， apixaban and edoxaban， had been established according to drug instruction， as well as warning levels beyond the basic review rules and corresponding intervention measures. After two rounds of expert consultation， 17 recommendations for prescription review were formed regarding some clinical drug use that were not covered by the basic prescription review rules. With the progress of clinical research， this consensus will be further updated and adjusted； in addition， as this consensus does not cover all situations where anticoagulants are used in clinical practice， prescription reviewer must conduct personalized evaluations based on the specific situation of the patient.

关键词

抗凝药物处方适宜性审方规则临床应用专家共识

Keywords

prescription suitabilityprescription review rulesclinical applicationexpert consensus

references

《中国血栓性疾病防治指南》专家委员会.中国血栓性疾病防治指南[J].中华医学杂志，2018，98（36）：2861-2888.

Expert Committee of Chinese Guidelines for the Prevention and Treatment of Thrombotic Diseases. Guidelines for prevention and treatment of thrombotic diseases in China[J]. Natl Med J China，2018，98（36）：2861-2888.

王乔宇，武明芬，柳鑫，等. 2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南[J]. 中国临床药理学杂志，2021，37（21）：2999-3016.

WANG Q Y，WU M F，LIU X，et al. Guidelines for the selection and pharmaceutical care of anticoagulants for the prevention and treatment of venous thromboembolism in China of 2021[J]. Chin J Clin Pharmacol，2021，37（21）：2999-3016.

中华医学会临床药学分会《磺达肝癸钠药学实践专家共识》编写工作组.磺达肝癸钠药学实践专家共识[J].医药导报，2022，41（11）：1571-1581.

Working Group for the Preparation of Expert Consensus on Pharmaceutical Practice of Fondaparinux Sodium，Clinical Pharmacy Society of Chinese Medical Association. Expert consensus on the pharmaceutical practice of fondaparinux sodium[J]. Her Med，2022，41（11）：1571-1581.

CLANCY T E，BAKER E H，MAEGAWA F A，et al. AHPBA guidelines for managing VTE prophylaxis and anticoagulation for pancreatic surgery[J]. HPB，2022，24（5）：575-585.

中华医学会呼吸病学分会肺栓塞与肺血管病学组，中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会，全国肺栓塞与肺血管病防治协作组.肺血栓栓塞症诊治与预防指南[J].中华医学杂志，2018，98（14）：1060-1087.

Pulmonary Embolism and Pulmonary Vascular Disease Group，Chinese Society of Respiratory Medicine，Pulmonary Embolism and Pulmonary Vascular Disease Working Committee，Respiratory Medicine Branch，Chinese Medical Doctor Association，National Pulmonary Embolism and Pulmonary Vascular Disease Prevention and Treatment Collaboration Group. Guidelines for diagnosis，treatment and prevention of pulmonary thromboembolism[J]. Natl Med J China，2018，98（14）：1060-1087.

JANUARY C T，WANN L S，CALKINS H，et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation：a report of the American College of Cardio-logy/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons[J]. Circulation，2019，140（2）：e125-e151.

STEFFEL J，COLLINS R，ANTZ M，et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Europace，2021，23（10）：1612-1676.

CHONG D T，ANDREOTTI F，VERHAMME P，et al. Direct oral anticoagulants in Asian patients with atrial fibrillation：consensus recommendations by the Asian Pacific Society of Cardiology on strategies for thrombotic and bleeding risk management[J]. Eur Cardiol，2021，16：e23.

国家卫生健康委员会脑卒中防治专家委员会房颤卒中防治专业委员会，中华医学会心电生理和起搏分会，中国医师协会心律学专业委员会.中国心源性卒中防治指南：2019[J].中华心律失常学杂志，2019，23（6）：463-484.

Professional Committee for the Prevention and Treatment of Atrial Fibrillation Stroke， Expert Committee on Stroke of the Prevention and Treatment of National Health Commission，Chinese Medical Association Electrophysiology and Pacing Branch，Cardiology Professional Committee of Chinese Medical Doctor Association. Guideline on prevention and treatment of cardiogenic stroke：2019 [J]. Chin J Card Arrhythm，2019，23（6）：463-484.

KEARON C，AKL E A，ORNELAS J，et al. Antithrombotic therapy for VTE disease：chest guideline and expert panel report[J]. Chest，2016，149（2）：315-352.

STEVENS S M，WOLLER S C，KREUZIGER L B，et al. Antithrombotic therapy for VTE disease：second update of the CHEST guideline and expert panel report[J]. Chest，2021，160（6）：e545-e608.

ORTEL T L，NEUMANN I，AGENO W，et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism：treatment of deep vein thrombosis and pulmonary embolism[J]. Blood Adv，2020，4（19）：4693-4738.

AGENO W，BEYER-WESTENDORF J，GARCIA D A，et al. Guidance for the management of venous thrombosis in unusual sites[J]. J Thromb Thrombolysis，2016，41（1）：129-143.

European Association for the Study of the Liver. EASL clinical practice guidelines：vascular diseases of the liver[J]. J Hepatol，2016，64（1）：179-202.

NORTHUP P G，GARCIA-PAGAN J C，GARCIA-TSAO G，et al. Vascular liver disorders，portal vein thrombosis，and procedural bleeding in patients with liver disease：2020 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology，2021，73（1）：366-413.

SIMONETTO D A，SINGAL A K，GARCIA-TSAO G，et al. ACG clinical guideline：disorders of the hepatic and mesenteric circulation[J]. Am J Gastroenterol，2020，115（1）：18-40.

中华医学会消化病学分会肝胆疾病学组. 肝硬化门静脉血栓管理专家共识：2020年，上海[J]. 中华肝脏病杂志，2020，28（12）：999-1007.

Hepatobiliary Disease Study Group，Chinese Society of Gastroenterology，Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis：2020，Shanghai[J]. Chin J Hepatol，2020，28（12）：999-1007.

LOFFREDO L，PASTORI D，FARCOMENI A，et al. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis：a systematic review and meta-analysis[J]. Gastroenterology，2017，153（2）：480-487.e1.

YAO C，ZHAO M，IBRAHIM B，et al. Anticoagulation for the treatment of portal vein thrombosis in cirrhosis：a systematic review and meta-analysis of comparative stu-dies[J]. J Clin Exp Hepatol，2023，13（3）：404-413.

ZHANG Z H，ZHANG J W，HE P，et al. Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients[J]. Medicine，2017，96（42）：e8256.

SENZOLO M，PIANO S，SHALABY S，et al. Comparison of fondaparinux and low-molecular-weight heparin in the treatment of portal vein thrombosis in cirrhosis[J]. Am J Med，2021，134（10）：1278-1285.e2.

NAYMAGON L，TREMBLAY D，ZUBIZARRETA N，et al. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis[J]. Blood Adv，2020，4（4）：655-666.

KOH J H，LIEW Z H，NG G K，et al. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis：a systematic review and meta-analysis[J]. Dig Liver Dis，2022，54（1）：56-62.

TILSED J V，CASAMASSIMA A，KURIHARA H，et al. ESTES guidelines：acute mesenteric ischaemia[J]. Eur J Trauma Emerg Surg，2016，42（2）：253-270.

BJÖRCK M，KOELEMAY M，ACOSTA S，et al. Editor’s choice： management of the diseases of mesenteric arteries and veins：clinical practice guidelines of the European Society of Vascular Surgery（ESVS）[J]. Eur J Vasc Endovasc Surg，2017，53（4）：460-510.

中国医师协会急诊医师分会，解放军急救医学专业委员会，中华医学会急诊医学分会，等. 2020年中国急性肠系膜缺血诊断与治疗专家共识[J]. 中华急诊医学杂志，2020，29（10）：1273-1281.

Emergency Physicians Branch of the Chinese Medical Doctor Association，PLA Emergency Medicine Professional Committee，Emergency Medicine Branch of Chinese Medical Association，et al. Expert consensus on diagnosis and treatment of acute mesenteric ischemia in China of 2020[J]. Chin J Emerg Med，2020，29（10）：1273-1281.

BALA M，CATENA F，KASHUK J，et al. Acute mesenteric ischemia：updated guidelines of the World Society of Emergency Surgery[J]. World J Emerg Surg，2022，17（1）：54.

SALIM S，ZARROUK M，ELF J，et al. Improved prognosis and low failure rate with anticoagulation as first-line therapy in mesenteric venous thrombosis[J]. World J Surg，2018，42（11）：3803-3811.

AGENO W，RIVA N，SCHULMAN S，et al. Long-term clinical outcomes of splanchnic vein thrombosis：results of an international registry[J]. JAMA Intern Med，2015，175（9）：1474-1480.

JOH J H，KIM D I. Mesenteric and portal vein thrombosis：treated with early initiation of anticoagulation[J]. Eur J Vasc Endovasc Surg，2005，29（2）：204-208.

FERRO J M，BOUSSER M G，CANHÃO P，et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis：endorsed by the European Academy of Neurology[J]. Eur Stroke J，2017，2（3）：195-221.

中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国颅内静脉血栓形成诊断和治疗指南2019[J]. 中华神经科杂志，2020，53（9）：648-663.

Chinese Society of Neurology，Group of Cerebrovascular Diseases of Chinese Society of Neurology. Chinese guidelines for diagnosis and treatment of cerebral venous thrombosis 2019[J]. Chin J Neurol，2020，53（9）：648-663.

COUTINHO J M，FERRO J M，CANHÃO P，et al. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis[J]. Stroke，2010，41（11）：2575-2580.

MISRA U K，KALITA J，CHANDRA S，et al. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis：a randomized controlled trial[J]. Eur J Neurol，2012，19（7）：1030-1036.

COUTINHO J，DE BRUIJN S F，DEVEBER G，et al. Anticoagulation for cerebral venous sinus thrombosis[J]. Cochrane Database Syst Rev，2011，2011（8）：CD002005.

FERRO J M，COUTINHO J M，DENTALI F，et al. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis：a randomized clinical trial[J]. JAMA Neurol，2019，76（12）：1457-1465.

YAGHI S，SHU L Q，BAKRADZE E，et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis（ACTION-CVT）：a multicenter international study[J]. Stroke，2022，53（3）：728-738.

PAN L Q，WANG M Q，ZHOU D，et al. Efficacy and safety of rivaroxaban in cerebral venous thrombosis：insights from a prospective cohort study[J]. J Thromb Thrombolysis，2022，53（3）：594-600.

BOSE G，GRAVELINE J，YOGENDRAKUMAR V，et al. Direct oral anticoagulants in treatment of cerebral venous thrombosis：a systematic review[J]. BMJ Open，2021，11（2）：e040212.

LI H J，YAO M L，LIAO S J，et al. Comparison of novel oral anticoagulants and vitamin K antagonists in patients with cerebral venous sinus thrombosis on efficacy and safety：a systematic review[J]. Front Neurol，2020，11：597623.

顾建平，徐克，滕皋军. 下肢深静脉血栓形成介入治疗规范的专家共识：第2版[J]. 介入放射学杂志，2019，28（1）：1-10.

GU J P，XU K，TENG G J. Expert consensus on the standard of interventional therapy for lower extremity deep venous thrombosis：2nd edition[J]. J Interv Radiol，2019，28（1）：1-10.

KAKKOS S K，GOHEL M，BAEKGAARD N，et al. Editor’s choice： European Society for Vascular Surgery（ESVS）2021 clinical practice guidelines on the management of venous thrombosis[J]. Eur J Vasc Endovasc Surg，2021，61（1）：9-82.

中华医学会心血管病学分会，中华心血管病杂志编辑委员会. 中国左心耳封堵预防心房颤动卒中专家共识：2019[J] . 中华心血管病杂志，2019，47（12）：937-955.

Chinese Society of Cardiology，Editorial Board of Chinese Journal of Cardiology. 2019 Chinese Society of Cardiology（CSC） expert consensus statement on left atrial appendage closure in the prevention of stroke in patients with atrial fibrillation[J]. Chin J Cardiol，2019，47（12）：937-955.

GLIKSON M，WOLFF R，HINDRICKS G，et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion： an update[J]. Europace，2020，22（2）：184.

TAY E，PAUL B，SHARP J，et al. Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation：clinical expert opinion and consensus statement for the Asian-Pacific region[J]. J Interv Card Electrophysiol，2021，61（2）：269-281.

SAW J，HOLMES D R，CAVALCANTE J L，et al. SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure[J]. JACC Cardiovasc Interv，2023，16（11）：1384-1400.

EITEL C，KOCH J，SOMMER P，et al. Novel oral anti-coagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation[J]. Europace，2013，15（11）：1587-1593.

WU S，YANG Y M，ZHU J，et al. Meta-analysis of ef-ficacy and safety of new oral anticoagulants compared with uninterrupted vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation[J]. Am J Cardiol，2016，117（6）：926-934.

KARASOY D，GISLASON G H，HANSEN J，et al. Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding：long-term follow-up in nationwide cohort of Denmark[J]. Eur Heart J，2015，36（5）：307-14a.

FLEDDERMANN A，ECKERT R，MUSKALA P，et al. Efficacy of direct acting oral anticoagulant drugs in treatment of left atrial appendage thrombus in patients with atrial fibrillation[J]. Am J Cardiol，2019，123（1）：57-62.

ROBINSON A A，TRANKLE C R，EUBANKS G，et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi[J]. JAMA Cardiol，2020，5（6）：685-692.

JONES D A，WRIGHT P，ALIZADEH M A，et al. The use of novel oral anticoagulants compared to vitamin K antagonists（warfarin）in patients with left ventricular thrombus after acute myocardial infarction[J]. Eur Heart J Cardiovasc Pharmacother，2021，7（5）：398-404.

OTTO C M，NISHIMURA R A，BONOW R O，et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease：a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation，2021，143（5）：e72-e227.

HINDRICKS G，POTPARA T，DAGRES N，et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery（EACTS）：the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology（ESC） developed with the special contribution of the European Heart Rhythm Association（EHRA）of the ESC[J]. Eur Heart J，2021，42（5）：373-498.

中华医学会心电生理和起搏分会，中国医师协会心律学专业委员会，中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动：目前的认识和治疗建议：2021[J]. 中华心律失常学杂志，2022，26（1）：15-88.

Chinese Society of Pacing and Electrophysiology， Professional Committee of Cardiology， the Chinese Medical Doctor Association， Expert Working Committee on the Prevention and Treatment of Atrial Fibrillation，Atrial Fibrillation Center Union of China.Current knowledge and management of atrial fibrillation：consensus of Chinese experts：2021[J]. Chin J Card Arrhythm，2022，26（1）：15-88.

中华医学会胸心血管外科分会瓣膜病外科学组.心脏瓣膜外科抗凝治疗中国专家共识[J].中华胸心血管外科杂志，2022，38（3）：164-174.

The Group of Valve Surgery，Chinese Society of Thoracic and Cardiovascular Surgery. Consensus of Chinese experts on anticoagulant therapy in cardiac valve surgery[J]. Chin J Thorac Cardiovasc Surg，2022，38（3）：164-174.

OTTO C M，NISHIMURA R A，BONOW R O，et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease：executive summary：a report of the American College of Cardiology/American Heart Associa-tion Joint Committee on clinical practice guidelines[J]. Circulation，2021，143（5）：e35-e71.

BAUMGARTNER H，FALK V，BAX J J，et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J，2017，38（36）：2739-2791.

马青变，郑亚安，朱继红，等. 中国急性血栓性疾病抗栓治疗共识[J]. 中国急救医学，2019，39（6）：501-531.

MA Q B，ZHENG Y A，ZHU J H，et al. Consensus of antithrombotic therapy for acute thrombotic diseases in China[J]. Chin J Crit Care Med，2019，39（6）：501-531.

SOBEL M，VERHAEGHE R. Antithrombotic therapy for peripheral artery occlusive disease：American College of Chest Physicians evidence-based clinical practice guidelines：8th edition[J]. Chest，2008，133（6 Suppl）：815S-843S.

中华医学会风湿病学分会.抗磷脂综合征诊断和治疗指南[J].中华风湿病学杂志，2011，15（6）：407-410.

Chinese Society of Rheumatology. Guidelines for diagnosis and treatment of antiphospholipid syndrome[J]. Chin J Rheumatol，2011，15（6）：407-410.

TEKTONIDOU M G，ANDREOLI L，LIMPER M，et al. EULAR recommendations for the management of antiphospholipid syndrome in adults[J]. Ann Rheum Dis，2019，78（10）：1296-1304.

COHEN H，CUADRADO M J，ERKAN D，et al. 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends[J]. Lupus，2020，29（12）：1571-1593.

KHAIRANI C D，BEJJANI A，PIAZZA G，et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes：meta-analysis of randomized trials[J]. J Am Coll Cardiol，2023，81（1）：16-30.

王学东，吴永贵.安徽省成人肾病综合征分级诊疗指南：2016年版[J]. 安徽医学，2017，38（5）：523-536.

WANG X D，WU Y G. Guidelines for graded diagnosis and treatment of adult nephrotic syndrome in Anhui Province：2016 edition[J]. Anhui Med J，2017，38（5）：523-536.

Kidney Disease：Improving Global Outcomes（KDIGO）Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular di-seases[J]. Kidney Int，2021，100（4S）：S1-S276.

BOYER O，SCHAEFER F，HAFFNER D，et al. Management of congenital nephrotic syndrome：consensus recommendations of the ERKNet-ESPN Working Group[J]. Nat Rev Nephrol，2021，17（4）：277-289.

中华医学会血液学分会血栓与止血学组.易栓症诊断与防治中国指南：2021年版[J].中华血液学杂志，2021，42（11）：881-888.

Thrombosis and Hemostasis Group，Chinese Society of Hematology. Chinese guidelines for diagnosis，prevention and treatment of thrombophilia：2021[J]. Chin J Hematol，2019，42（11）：881-888.

中国成人血小板减少症急诊管理共识专家组.中国成人血小板减少症急诊管理专家共识[J].中华急诊医学杂志，2022，31（2）：161-168.

Chinese Consensus Expert Group on Emergency Management of Adult Thrombocytopenia. Expert consensus on emergency management of adult thrombocytopenia in China[J]. Chin J Emerg Med，2022，31（2）：161-168.

中国医师协会心血管内科医师分会血栓防治专业委员会，《中华医学杂志》编辑委员会.肝素诱导的血小板减少症中国专家共识：2017[J].中华医学杂志，2018，98（6）：408-417.

Thrombosis Prevention and Treatment Committee， Branch of Cardiovascular Physicians， Chinese Medical Doctor Association，Editorial Board of Chinese Medical Journal. Chinese expert consensus on heparin-induced thrombocytopenia：2017[J]. Natl Med J China，2018，98（6）：408-417.

CUKER A，AREPALLY G M，CHONG B H，et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism：heparin-induced thrombocytopenia[J]. Blood Adv，2018，2（22）：3360-3392.

MARCUCCI R，BERTEOTTI M，GORI AM，et al. Heparin-induced thrombocytopenia：position paper from the Italian Society on Thrombosis and Haemostasis（SISET）[J]. Blood Transfus，2021，19（1）：14-23.

中国微循环学会周围血管疾病专业委员会.静脉血栓栓塞症合并慢性肾脏疾病的抗凝治疗微循环专家共识[J].血管与腔内血管外科杂志，2021，7（1）：1-13.

Peripheral Vascular Disease Committee of Chinese So-ciety of Microcirculation. Microcirculation Expert Consensus of anticoagulation in venous thromboembolism combined with chronic kidney disease[J]. J Vasc Endovasc Surg，2021，7（1）：1-13.

国家妇幼健康研究会生殖免疫学专业委员会专家共识编写组. 复发性流产抗血栓药物治疗中国专家共识[J]. 中华生殖与避孕杂志，2022，42（12）：1207-1217.

Experts Consensus Group on Reproductive Immunology，Maternal and Child Health Research Association. Antithrombotic drug use for recurrent spontaneous abortion：a Chinese expert consensus[J]. Chin J Reprod Contracept，2022，42（12）：1207-1217.

低分子肝素防治自然流产中国专家共识编写组.低分子肝素防治自然流产中国专家共识[J].中华生殖与避孕杂志，2018，38（9）：701-708.

Chinese Experts Consensus Group on Low Molecular Weight Heparin for Prevention and Treatment of Spontaneous Abortion. Chinese experts consensus on prevention and treatment of spontaneous abortion with low molecular weight heparin[J]. Chin J Reprod Contracept，2018，38（9）：701-708.

中华医学会围产医学分会. 产科抗磷脂综合征诊断与处理专家共识[J].中华围产医学杂志，2020，23（8）：517-522.

Chinese Society of Perinatal Medicine. Expert consensus on diagnosis and management of obstetric antiphospholipid syndrome[J]. Chin J Perinat Med，2019，23（8）：517-522.

中华医学会风湿病学分会，国家皮肤与免疫疾病临床医学研究中心，中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志，2020，59（3）：172-185.

Chinese Society of Rheumatology，National Clinical Research Center for Dermatologic and Immunologic Di-seases，Chinese systemic Lupus Treatment and Research Group.2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus[J]. Chin J Intern Med，2020，59（3）：172-185.

Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome：a guideline[J]. Fertil Steril，2016，106（7）：1634-1647.

ZHAO L，BI S Q，FU J H，et al. Retrospective analysis of fondaparinux and low-molecular-weight heparin in the treatment of women with recurrent spontaneous abortion[J]. Front Endocrinol，2021，12：717630.

MONAGLE P，CHAN A K C，GOLDENBERG N A，et al. Antithrombotic therapy in neonates and children：antithrombotic therapy and prevention of thrombosis，9th ed：American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest，2012，141（2 Suppl）：e737S-e801S.

MONAGLE P，CUELLO C A，AUGUSTINE C，et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism：treatment of pediatric venous thromboembolism[J]. Blood Adv，2018，2（22）：3292-3316.

YOUNG G，YEE D L，O’BRIEN S H，et al. FondaKIDS：a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age[J]. Pediatr Blood Cancer，2011，57（6）：1049-1054.

SHEN X F，WILE R，YOUNG G. FondaKIDS Ⅲ：a long-term retrospective cohort study of fondaparinux for treatment of venous thromboembolism in children[J]. Pediatr Blood Cancer，2020，67（8）：e28295.

中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会（CSCO）肿瘤患者静脉血栓防治指南：2020[M]. 北京：人民卫生出版社，2020：13-41.

The Guide Working Committee of Chinese Society of Clinical Oncology. Guidelines of Chinese Society of Clinical Oncology（CSCO）：venous thromboembolism prophylaxis and treatment guideline in patients with cancer[M]. Beijing：People’s Medical Publishing House，2020：13-41.

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology：cancer-associated venous thromboembolic disease：version 2.2023[EB/OL].[2023-06-01].https：//www.nccn.org/guidelines/guidelines-detail?category=3&id=1423. detail?category=3&id=1423https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1423.detail?category=3&id=1423.

LYMAN G H，CARRIER M，AY C，et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism：prevention and treatment in patients with cancer[J]. Blood Adv，2021，5（7）：1953.

KEY N S，KHORANA A A，KUDERER N M，et al. Venous thromboembolism prophylaxis and treatment in patients with cancer：ASCO guideline update[J]. J Clin Oncol，2023，41（16）：3063-3071.

FALANGA A，AY C，DI NISIO M，et al. Venous throm-boembolism in cancer patients：ESMO clinical practice guideline[J]. Ann Oncol，2023，34（5）：452-467.

FARGE D，FRERE C，CONNORS J M，et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer，including patients with COVID-19[J]. Lancet Oncol，2022，23（7）：e334-e347.

国际血管联盟中国分会，中国老年医学学会周围血管疾病管理分会. 输液导管相关静脉血栓形成防治中国专家共识：2020版[J]. 中国实用外科杂志，2020，40（4）：377-383.

International Vascular Alliance China Branch，Peripheral Vascular Disease Management Branch of the Chinese Geriatric Association. Chinese expert consensus on prevention and treatment catheter related venous thrombosis：2020 edition[J]. Chin J Pract Surg，2020，40（4）：377-383.

ZWICKER J I，CONNOLLY G，CARRIER M，et al. Catheter-associated deep vein thrombosis of the upper extremity in cancer patients：guidance from the SSC of the ISTH[J]. J Thromb Haemost，2014，12（5）：796-800.

MALIK A H，YANDRAPALLI S，SHETTY S，et al. Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation：a meta-analysis[J]. Europace，2020，22（3）：361-367.

中华医学会心血管病学分会，中国老年学学会心脑血管病专业委员会. 华法林抗凝治疗的中国专家共识[J]. 中华内科杂志，2013，52（1）：76-82.

Chinese Society of Cardiology，Committee of Cardio-cerebral-Vascular of the Chinese Gerontological Society. Chinese expert consensus on warfarin anticoagulant therapy [J].Chin J Intern Med，2013，52（1）：76-82.

KUMBHANI D J，CANNON C P，BEAVERS C J，et al. 2020 ACC expert consensus decision pathway for anti-coagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease：a report of the American College of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol，2021，77（5）：629-658.

中华医学会心血管病学分会，中华心血管病杂志编辑委员会. 冠心病合并心房颤动患者抗栓管理中国专家共识[J]. 中华心血管病杂志，2020，48（7）：552-564.

Chinese Society of Cardiology，Editorial Board of Chinese Journal of Cardiology. Antithrombotic management of patients with atrial fibrillation and coronary artery disease：expert consensus document of Chinese Society of Cardiology[J]. Chin J Cardiol，2020，48（7）：552-564.

中华医学会心血管病学分会，中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南：2019[J]. 中华心血管病杂志，2019，47（10）：766-783.

Chinese Society of Cardiology，Editorial Board of Chinese Journal of Cardiology. 2019 Chinese Society of Cardiology（CSC）guidelines for the diagnosis and ma-nagement of patients with ST-segment elevation myocardial infarction[J]. Chin J Cardiol，2019，47（10）：766-783.

中国医师协会介入医师分会，中华医学会放射学分会介入专业委员会，中国静脉介入联盟. 下肢深静脉血栓形成介入治疗规范的专家共识：第2版[J]. 中华医学杂志，2018，98（23）：1813-1821.

Interventional Physician Branch of Chinese Medical Doctor Association，Interventional Professional Committee， Chinese Society of Radiology，China Intravenous Intervention Alliance. Expert consensus on the standard of interventional treatment for deep venous thrombosis of lower extremities：2nd edition[J]. Natl Med J China，2018，98（23）：1813-1821.

BATES S M，RAJASEKHAR A，MIDDELDORP S，et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism：venous thromboembolism in the context of pregnancy[J]. Blood Adv，2018，2（22）：3317-3359.

American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 196：thromboembolism in pregnancy[J]. Obstet Gynecol，2018，132（1）：e1-e17.

Queensland Health. Queensland clinical guideline： venous thromboembolism（VTE）prophylaxis in pregnancy and the puerperium[EB/OL].[2023-08-25]. https：//www.health.qld.gov.au/_data/assets/pdf_file/0011/140024/g-vte.pdfhttps://www.health.qld.gov.au/_data/assets/pdf_file/0011/140024/g-vte.pdf.

REGITZ-ZAGROSEK V，ROOS-HESSELINK J W，BAUERSACHS J，et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy[J]. Eur Heart J，2018，39（34）：3165-3241.

中华医学会妇产科学分会产科学组. 妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识[J]. 中华妇产科杂志，2021，56（4）：236-243.

Obstetric Subgroup， Chinese Society of Obstetrics and Gynecology.Expert consensus on prevention，diagnosis and treatment of venous thromboembolism during pregnancy and puerperium[J]. Chin J Obstet Gynecol，2021，56（4）：236-243.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

胃肠间质瘤靶向药物伊马替尼的个体化用药管理中国专家共识 ^Δ

东北三省超说明书用药专家共识（实体瘤、血液病篇）

集中带量采购政策下山东省调脂药物临床综合评价专家共识

心血管慢病药品临床综合评价杭州专家共识